Set Your Goal: Engaging Go/No-Go Active Learning

Overview

This study will test a computational model reinforcement learning in depression and anxiety and test the extent to which the computational model predicts response to an adapted version of behavioral activation psychotherapy. The model will be based on a data from a computer task of reinforcement learning during 3T functional magnetic resonance imaging at baseline.

Full Title of Study: “Computational Modeling of Reinforcement Learning in Depression”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: N/A
    • Intervention Model: Single Group Assignment
    • Primary Purpose: Treatment
    • Masking: None (Open Label)
  • Study Primary Completion Date: March 1, 2019

Detailed Description

The dysfunction of reinforcement learning is emerging as a transdiagnostic dimension of mood and anxiety. Computational models of reinforcement learning may expedite our ability to identify predictors of response, thereby improving efficacy rates. We will will, first, examine the neural substrates of reinforcement learning in depression and anxiety, and, second, test a computational model of reinforcement learning as a predictor of response to an adapted version of behavioral activation psychotherapy. Subjects (N=10) will be enrolled in a two week evaluation, followed with a nine week weekly intervention program. Assessments will be conducted at baseline, and during the intervention as the 3-, 6-, 9-week follow-ups. Reinforcement learning will be measured using 3T magnetic resonance imaging during a computer task. All other measures include structured clinical interviews, questionnaires, and computer tasks.

Interventions

  • Behavioral: Go/No-Go Active Learning (GOAL)
    • Behavioral Activation psychotherapy adapted to engage go/no-go learning

Arms, Groups and Cohorts

  • Experimental: Go/No-Go Active Learning (GOAL)
    • Adaptation of Behavioral Activation, focused on reinforcement learning strategies.

Clinical Trial Outcome Measures

Primary Measures

  • Integrated Bayesian Information Criterion (BIC) score based on models using modified Q-learning models with two pairs of action values (go and no-go) for each state.
    • Time Frame: Baseline (Week 0)
    • Models will include a learning rate, a slope of the softmax rule, noise factor, a bias factor to the action-value for ‘go’, and a Pavlovian factor.

Participating in This Clinical Trial

Inclusion Criteria

  • Between the ages of 21 and 40 – Physically healthy – Right handed – Normal or corrected to normal vision – Scores equal or higher of (a) 24 on Inventory of Depressive Symptomatology, Self Report, or (b) 15 on the Generalized Anxiety Disorder Self Report. Exclusion Criteria:

  • Not currently in therapy or taking medications for anxiety or depression – No contraindications for the magnetic resonance scan (claustrophobic) – No history of head trauma, seizures, loss of consciousness – Not taking hormone replacement, not pregnant – No imminent suicidality – No report of excessive alcohol or drug use in past three months

Gender Eligibility: All

Minimum Age: 21 Years

Maximum Age: 40 Years

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Northwestern University
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • Jackie Gollan, Ph.D., Principal Investigator, Associate Professor of Psychiatry and Behavioral Science

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.